ARTICLE | Clinical News
Bepreve: Additional Phase III data
November 16, 2009 8:00 AM UTC
Pooled data from 2 placebo-controlled, U.S. Phase III trials in 157 patients showed that 1.5% Bepreve was as effective in suppressing ocular itching in patients with more severe grades of itching as i...